{"gene":"PINK1","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2010,"finding":"PINK1 accumulation on mitochondria is regulated by voltage-dependent proteolysis: on healthy, polarized mitochondria PINK1 is kept at low levels, while mitochondrial damage (depolarization) causes rapid accumulation of full-length PINK1 on the outer mitochondrial membrane. PINK1 accumulation is both necessary and sufficient for Parkin recruitment to mitochondria, and PINK1 acts upstream of Parkin in the mitophagy pathway.","method":"Genetic epistasis (disease-causing mutations dissecting pathway steps), biochemical fractionation, fluorescence microscopy of mitochondrial PINK1 and Parkin localization in mammalian cells with uncoupler treatment","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal epistasis analysis combined with biochemical fractionation and live-cell imaging, replicated across multiple subsequent studies","pmids":["20126261"],"is_preprint":false},{"year":2014,"finding":"PINK1 directly phosphorylates ubiquitin at Ser65, homologous to Ser65 in the Parkin ubiquitin-like domain. Phospho-ubiquitin (pS65-Ub) activates Parkin E3 ubiquitin ligase activity in cell-free assays, and the phosphomimetic ubiquitin S65D binds and activates Parkin. Expression of non-phosphorylatable ubiquitin S65A inhibits Parkin translocation to damaged mitochondria, establishing a feed-forward activation mechanism.","method":"Mass spectrometry identification of endogenous phosphorylation site; in vitro kinase assay with recombinant TcPINK1 and ubiquitin; cell-free Parkin activation assay; phosphomimetic/phospho-dead ubiquitin mutant overexpression in cells","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified components, mass spectrometry identification, mutagenesis, independently replicated by multiple labs","pmids":["24751536"],"is_preprint":false},{"year":2015,"finding":"PINK1 recruits autophagy receptors NDP52 and optineurin (but not p62) to mitochondria independently of Parkin to initiate mitophagy. Once recruited, NDP52 and optineurin recruit autophagy initiation factors ULK1, DFCP1, and WIPI1 to focal spots proximal to mitochondria upstream of LC3, placing PINK1-generated phospho-ubiquitin as the primary autophagy signal on mitochondria.","method":"CRISPR/Cas9 knockout of five autophagy receptors in HeLa cells; fluorescence imaging of receptor recruitment; epistasis analysis of receptor dependence for mitophagy flux","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-edited knockout cells with multiple receptor knockouts, orthogonal imaging and flux assays, single rigorous study with strong controls","pmids":["26266977"],"is_preprint":false},{"year":2013,"finding":"PINK1 phosphorylates mitofusin 2 (Mfn2) on the mitochondrial outer membrane, and phospho-Mfn2 acts as a receptor for Parkin. Parkin binds Mfn2 in a PINK1-dependent manner and promotes its ubiquitination. Ablation of Mfn2 in mouse cardiomyocytes prevents depolarization-induced Parkin translocation to mitochondria and suppresses mitophagy.","method":"Co-immunoprecipitation; PINK1 in vitro phosphorylation assay with Mfn2; conditional cardiac Mfn2 knockout mice; mitophagy assays","journal":"Science (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and in vitro phosphorylation plus KO mouse model, single lab; subsequent work questions universality of this receptor","pmids":["23620051"],"is_preprint":false},{"year":2018,"finding":"The mechanism of Parkin activation by PINK1 involves large-scale domain rearrangement: phospho-Ubl (phosphorylated by PINK1 at Ser65) rebinds to the parkin core at the unique parkin domain (UPD) and releases the catalytic RING2 domain from autoinhibition. A conserved linker ACT element between Ubl and UPD mimics RING2 interactions to facilitate release. Crystal structure of phosphorylated human parkin at 1.8 Å reveals the phospho-Ubl binding site on UPD lined by AR-JP disease mutations.","method":"Hydrogen-deuterium exchange mass spectrometry of full-length human parkin during activation; 1.8 Å crystal structure of phosphorylated human parkin; structure-guided mutagenesis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with HDX-MS and mutagenesis in a single rigorous study providing direct mechanistic insight","pmids":["29995846"],"is_preprint":false},{"year":2021,"finding":"PINK1 is activated through a multi-step mechanism involving: (1) dimerization and trans-autophosphorylation captured in a cryo-EM structure of a symmetric PhPINK1 dimer; (2) conformational change upon autophosphorylation to an active ubiquitin kinase state; (3) an N-terminal helix orienting unphosphorylated PINK1 on the mitochondrial outer membrane. Regulatory oxidation of PINK1 also modulates its activity.","method":"Crystallography of unphosphorylated PhPINK1; cryo-EM structures of PhPINK1 dimer during trans-autophosphorylation and of phosphorylated active state; in vitro phosphorylation assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple crystal and cryo-EM structures combined with biochemical phosphorylation assays in a single comprehensive study","pmids":["34933320"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structure at 3.1 Å resolution of dimeric human PINK1 stabilized at an endogenous TOM-VDAC array reveals: PINK1 enters mitochondria through the proximal TOM40 barrel guided by TOM7 and TOM22; TOM5 and TOM20 both bind PINK1 kinase C-lobes; a symmetric arrangement of two TOM core complexes around a central VDAC2 dimer is facilitated by TOM5 and TOM20. The N-terminal–C-terminal extension module of PINK1 interacts with the cytosolic domain of Tom20 to stabilize PINK1 at the TOM complex.","method":"3.1 Å cryo-EM structure of endogenous human PINK1–TOM–VDAC complex; mutagenesis of PINK1–Tom20 interaction interface; mitophagy functional assays in cell lines, dopamine neurons, and midbrain organoids","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — near-atomic cryo-EM structure combined with mutagenesis and functional validation in multiple cell systems","pmids":["40080546"],"is_preprint":false},{"year":2024,"finding":"Upon mitochondrial stress, PINK1 induces formation of a PINK1–TOM–TIM23 supercomplex in human cell lines, dopamine neurons, and midbrain organoids. PINK1 is required to stably tether TOM to TIM23; this tethering depends on an interaction between the PINK1 N-terminal–C-terminal extension module and the cytosolic domain of Tom20. Disruption of this interaction by designer or PD-associated PINK1 mutations inhibits downstream mitophagy.","method":"Co-immunoprecipitation and native gel electrophoresis of PINK1–TOM–TIM23 supercomplex; mutagenesis of PINK1 N-terminal module; mitophagy assays in dopamine neurons and midbrain organoids","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP establishing supercomplex, mutagenesis, functional validation in multiple physiologically relevant systems","pmids":["38416681"],"is_preprint":false},{"year":2018,"finding":"PINK1 autophosphorylation (at Ser205 in TcPINK1, equivalent to Ser228 in human PINK1) is required for substrate recognition; autophosphorylated PINK1 binds the Parkin Ubl domain with ~10-fold higher affinity than ubiquitin via a conserved interface. Multiple PINK1 molecules autophosphorylate in trans prior to binding and phosphorylating ubiquitin and Parkin.","method":"Enzyme kinetics; NMR spectroscopy of PINK1–Parkin Ubl interaction; mass spectrometry mapping of autophosphorylation site; SAXS; hydrogen-deuterium exchange","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR, enzyme kinetics, mass spectrometry, and SAXS in a single study with rigorous biochemical characterization","pmids":["29475881"],"is_preprint":false},{"year":2018,"finding":"Structural analysis of TcPINK1 kinase domain with non-hydrolyzable ATP analogue at 2.5 Å reveals a Ub/UBL-binding groove wider than the peptide-binding groove of PKA/PKC to accommodate the globular Ub/UBL head; crosslinking and structure-guided mutagenesis identified the PINK1-interacting surface on ubiquitin.","method":"2.5 Å crystal structure of TcPINK1–ATP analogue complex; crosslinking mass spectrometry; structure-guided mutagenesis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure combined with crosslinking and mutagenesis providing direct structural insight into substrate binding","pmids":["29991771"],"is_preprint":false},{"year":2016,"finding":"PINK1 autophosphorylation in Drosophila at Ser346 (identified by LC-MS/MS) is required for Parkin mitochondrial recruitment and for PINK1 kinase activity toward Parkin. Phosphorylation of Parkin by PINK1 is dispensable for Parkin translocation but required for Parkin activation. Autophosphorylation-deficient PINK1 fails to rescue pink1 null phenotypes.","method":"LC-MS/MS mapping of Drosophila PINK1 autophosphorylation; site-directed mutagenesis; Drosophila photoreceptor neuron degeneration model; mitochondrial Parkin recruitment assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mass spectrometry site identification with mutagenesis and functional rescue in Drosophila model, single lab","pmids":["27906179"],"is_preprint":false},{"year":2019,"finding":"PHB2 (inner mitochondrial membrane scaffold protein) stabilizes PINK1 on mitochondria; PHB2 depletion destabilizes PINK1, blocking Parkin/ubiquitin/OPTN recruitment and inhibiting mitophagy. PHB2 interacts with and inhibits the PARL protease; upon PHB2 depletion, PARL is activated and processes PGAM5, reducing PINK1 stability. Thus PHB2-PARL-PGAM5 constitutes a novel upstream regulatory axis for PINK1 stabilization.","method":"Co-immunoprecipitation of PHB2 with PARL; siRNA knockdown of PHB2, PARL, PGAM5; immunofluorescence of PINK1, Parkin, ubiquitin, OPTN mitochondrial recruitment; overexpression rescue experiments","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and multiple knockdown experiments with defined phenotypic readouts, single lab","pmids":["31177901"],"is_preprint":false},{"year":2021,"finding":"AMBRA1 is recruited to the outer mitochondrial membrane upon mitochondrial depolarization and interacts with PINK1 and ATAD3A (a transmembrane protein mediating PINK1 import and degradation). AMBRA1 downregulation reduces PINK1 levels via enhanced LONP1 protease-dependent degradation, decreasing PINK1-mediated ubiquitin phosphorylation and Parkin recruitment. ATAD3A silencing rescues defective PINK1 accumulation in AMBRA1-deficient cells.","method":"Co-immunoprecipitation of AMBRA1 with PINK1 and ATAD3A; siRNA knockdown of AMBRA1, ATAD3A, LONP1; immunoblotting of pS65-Ub and Parkin recruitment; mitophagy flux assays","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and epistatic knockdown analysis with defined readouts, single lab","pmids":["34798798"],"is_preprint":false},{"year":2023,"finding":"TIM23 (inner mitochondrial membrane translocase subunit) is identified by mass spectrometry as a component of the PINK1 complex. TIM23 downregulation decreases PINK1 levels and delays PINK1 autophosphorylation upon depolarization. TIM23 protects PINK1 from degradation by the mitochondrial protease OMA1; OMA1 inactivation rescues PINK1 accumulation defects caused by TIM23 downregulation and partially restores pathogenic PINK1 mutants that fail to interact with TIM23.","method":"Mass spectrometry of PINK1 co-immunoprecipitates; siRNA knockdown of TIM23 and OMA1; PINK1 autophosphorylation kinetics; co-immunoprecipitation of TIM23-PINK1","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mass spectrometry identification confirmed by Co-IP, epistatic knockdown analysis with kinetic readouts, single lab","pmids":["37160114"],"is_preprint":false},{"year":2016,"finding":"BNIP3 interacts with PINK1 at the outer mitochondrial membrane, suppresses PINK1 proteolytic cleavage, promotes accumulation of full-length PINK1, and thereby facilitates Parkin recruitment and PINK1/Parkin-mediated mitophagy. Inactivation of BNIP3 promotes PINK1 proteolytic processing and suppresses mitophagy. Hypoxia-induced BNIP3 expression increases full-length PINK1 levels.","method":"Co-immunoprecipitation of BNIP3 and PINK1; BNIP3 siRNA knockdown and overexpression; Parkin recruitment assays; Drosophila rescue experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with functional knockdown/overexpression validation and in vivo Drosophila confirmation, single lab","pmids":["27528605"],"is_preprint":false},{"year":2016,"finding":"PINK1 and Parkin influence the cell cycle by sequestering TBK1 at damaged mitochondria during mitophagy, thereby preventing TBK1 from performing its physiological role at centrosomes during mitosis. Loss of PINK1 and Parkin accelerates cell growth.","method":"Genetic interaction screen; TBK1 localization imaging at centrosomes vs. mitochondria; PINK1/Parkin loss-of-function cell proliferation assays; epistasis analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis and subcellular localization with functional proliferation readout, single lab","pmids":["31577952"],"is_preprint":false},{"year":2018,"finding":"Loss of PINK1 and Parkin leads to mtDNA-driven STING-dependent type I interferon inflammation in mice. PINK1/Parkin-mediated mitophagy restrains innate immunity by preventing release of mitochondrial DAMPs; concurrent loss of STING completely rescues inflammation, dopaminergic neuron loss, and motor defects in aged Prkn-/-;mutator mice.","method":"Pink1-/- and Prkn-/- mouse models with exhaustive exercise and mtDNA mutator backgrounds; genetic rescue by STING knockout; cytokine measurement; dopaminergic neuron quantification","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double/triple knockout mouse models, multiple orthogonal phenotypic readouts, single rigorous study","pmids":["30135585"],"is_preprint":false},{"year":2009,"finding":"PINK1 knockdown in SH-SY5Y cells induces mitochondrial fragmentation and mitophagy driven by mitochondrial ROS. Dominant-negative Drp1 inhibits both fission and mitophagy in PINK1-deficient cells, placing Drp1-dependent fission upstream of mitophagy in the PINK1 pathway. Overexpression of wild-type PINK1 suppresses toxin-induced mitophagy and increases mitochondrial interconnectivity.","method":"Stable shRNA PINK1 knockdown; mitochondrial morphology imaging; Drp1 dominant-negative epistasis; ROS measurement; autophagy marker quantification","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis with dominant-negative Drp1, stable knockdown with multiple readouts, single lab","pmids":["19279012"],"is_preprint":false},{"year":2022,"finding":"Neuronal Pink1 mRNA is cotransported with mitochondria and locally translated in neurites. The outer mitochondrial membrane protein SYNJ2BP and its binding partner SYNJ2 (via an RNA-binding domain) are required to tether Pink1 mRNA to mitochondria, enabling local PINK1 production for mitophagy activation far from the soma.","method":"RNA-FISH and live imaging of Pink1 mRNA in neurons; SYNJ2BP/SYNJ2 knockdown; RNA immunoprecipitation; local translation assays; mitophagy readouts in distal neuronal compartments","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct mRNA localization imaging combined with RNA-IP and functional knockdown with mitophagy readout in neurons, single rigorous study with multiple orthogonal methods","pmids":["35216662"],"is_preprint":false},{"year":2024,"finding":"Insulin signaling activates AKT/mTOR and inhibits AMPK, which in turn prevents SYNJ2BP phosphorylation within its PDZ domain; this phosphorylation is necessary for SYNJ2BP interaction with the RNA-binding protein SYNJ2 and Pink1 mRNA tethering to mitochondria. Loss of mitochondrial Pink1 mRNA association upon insulin addition is required for proper PINK1 protein activation as a ubiquitin kinase in the mitophagy pathway, placing PINK1 function under metabolic/insulin control. ApoE4-induced insulin resistance retains Pink1 mRNA at mitochondria and impairs PINK1 activity particularly in neurites.","method":"AMPK inhibition/activation experiments; phospho-site mutagenesis of SYNJ2BP PDZ domain; RNA immunoprecipitation; PINK1 ubiquitin kinase activity assays; Pink1 mRNA localization imaging in neurons","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — phospho-site mutagenesis, RNA-IP, kinase activity assays and mRNA localization imaging with multiple orthogonal methods in a single study","pmids":["38504131"],"is_preprint":false},{"year":2006,"finding":"PINK1 protein localizes to mitochondrial membranes in normal human brain (all cell types, punctate cytoplasmic pattern). Subcellular fractionation of human and rat brain confirms mitochondrial membrane localization. PINK1 is detected in a proportion of Lewy bodies in sporadic Parkinson's disease.","method":"Immunohistochemistry and western blotting with anti-PINK1 antibodies; subcellular fractionation of human and rat brain tissue","journal":"Brain : a journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct fractionation of primary human and rat brain tissue with validated antibodies, independent replication of localization finding","pmids":["16702191"],"is_preprint":false},{"year":2011,"finding":"PINK1 localizes exclusively to mitochondria in cardiomyocytes. Pink1-/- mice develop left ventricular dysfunction and pathological cardiac hypertrophy by 2 months of age with increased mitochondrial ROS, impaired mitochondrial function, fibrosis, and cardiomyocyte apoptosis, demonstrating PINK1 is required for maintaining mitochondrial function and redox homeostasis in the heart.","method":"PINK1 immunofluorescence/fractionation in cardiomyocytes; Pink1-/- mouse cardiac phenotyping; mitochondrial function assays; ROS measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model with defined cardiac phenotype and mitochondrial functional readouts, single lab","pmids":["21606348"],"is_preprint":false},{"year":2013,"finding":"Synphilin-1 interacts with PINK1 and is recruited to mitochondria in a PINK1-dependent manner. Once at mitochondria, synphilin-1 promotes PINK1-dependent mitophagy independently of Parkin by recruiting SIAH-1 E3 ubiquitin ligase to mitochondria, where SIAH-1 promotes mitochondrial protein ubiquitination and mitophagy. PINK1 disease mutants fail to recruit synphilin-1.","method":"Co-immunoprecipitation of synphilin-1 and PINK1; siRNA knockdown of synphilin-1 and SIAH-1; LC3/Lamp1 mitochondrial co-localization imaging; Atg5 knockdown epistasis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with multiple knockdown epistasis experiments and imaging readouts, single lab","pmids":["27334109"],"is_preprint":false},{"year":2003,"finding":"PINK1/BRPK encodes a serine/threonine-type protein kinase capable of autophosphorylation, as demonstrated with recombinant protein.","method":"Recombinant protein expression; in vitro autophosphorylation assay","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro autophosphorylation assay with recombinant protein, single lab, foundational characterization","pmids":["14607334"],"is_preprint":false},{"year":2010,"finding":"PINK1 activates AKT phosphorylation at Ser473 through activation of mTORC2, not PI3K. Rictor (mTORC2 component) is phosphorylated upon PINK1 overexpression. This cytoplasmic PINK1 activity promotes cell survival and motility independently of its mitochondrial functions.","method":"Overexpression of PINK1 in SH-SY5Y cells; immunoblotting for pAkt-Ser473; rapamycin and PI3K inhibitor controls; Rictor phosphorylation; cell motility assays","journal":"The Journal of biological chemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single overexpression study with indirect readouts, single lab, no direct kinase assay reconstituting PINK1→mTORC2→AKT","pmids":["21177249"],"is_preprint":false},{"year":2009,"finding":"FOXO3a transcription factor directly controls Pink1 transcription in mouse and human cells subjected to growth factor deprivation through evolutionarily conserved FOXO binding elements in the Pink1 promoter. PINK1 induction by FOXO3a is required for lymphocyte survival upon growth factor deprivation.","method":"FOXO3a overexpression and knockdown; Pink1 promoter-reporter assays; chromatin immunoprecipitation; PINK1 siRNA cell survival assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and promoter reporter assays combined with functional survival readout, single lab","pmids":["19276113"],"is_preprint":false},{"year":2015,"finding":"DJ-1 transcriptionally upregulates Pink1 by binding with Foxo3a and directly interacting with the pink1 promoter. DJ-1-null cells show decreased pink1 mRNA and Pink1 protein; the glycolytic and proliferative changes in DJ1-deficient cells are abrogated by Pink1 expression.","method":"RT-PCR and western blot of Pink1 in DJ1-null MEFs; chromatin immunoprecipitation of DJ1/Foxo3a at pink1 promoter; Pink1 rescue overexpression; metabolic assays","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP evidence of direct promoter binding with functional rescue, single lab","pmids":["25670069"],"is_preprint":false},{"year":2020,"finding":"PINK1 phosphorylates TUFm (mitochondrial Tu translation elongation factor) at Ser222, creating a phosphoswitch: unphosphorylated TUFm promotes mitophagy via a Parkin-independent route, while p-S222-TUFm is exported to the cytosol where it inhibits mitophagy by impeding Atg5-Atg12 formation. This self-antagonizing PINK1/TUFm mechanism provides robustness to mitophagy regulation.","method":"Co-immunoprecipitation of TUFm and PINK1; PINK1 kinase assay with TUFm; phospho-site mutagenesis (S222A/D); subcellular fractionation of p-S222-TUFm; Atg5-Atg12 formation assay; Drosophila genetic validation","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase assay, mutagenesis, fractionation and genetic validation in Drosophila, single lab","pmids":["33113344"],"is_preprint":false},{"year":2023,"finding":"PINK1 regulates selective ER clearance (ER-phagy) in addition to mitophagy during Drosophila development. PINK1 acts upstream to regulate both Parkin-dependent mitochondrial clearance and Keap1/Cullin3-dependent ER clearance. PINK1 regulates a change in Keap1 localization and Keap1-dependent ubiquitylation of the ER-phagy receptor Rtnl1 to facilitate ER removal. Parkin has the opposite function in ER clearance compared to mitochondrial clearance.","method":"Drosophila genetic epistasis (PINK1, parkin, keap1, cullin3, rtnl1 mutants); Keap1 localization imaging; Rtnl1 ubiquitylation assays; autophagy flux assays during development","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with localization and ubiquitylation assays in Drosophila developmental model, single lab","pmids":["37633267"],"is_preprint":false},{"year":2022,"finding":"Structural basis for feedforward Parkin activation: phospho-ubiquitin binds to two distinct sites on Parkin—a high-affinity site on RING1 controlling Parkin localization and a low-affinity site on RING0 that releases autoinhibition. The RING0 site has higher affinity for phospho-ubiquitin than for phosphorylated Ubl in trans. Parkin activation by micromolar tetra-phospho-ubiquitin chains, and a Parkin chimera with Ubl replaced by ubiquitin, is activated by PINK1 phosphorylation; mutation of the RING0 binding site abolishes activation.","method":"ITC; NMR titrations; ubiquitin vinyl sulfone activity assays; parkin chimera construction and PINK1 phosphorylation assays; mutagenesis of RING0 site","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ITC, NMR, and activity assays with mutagenesis in a single study with multiple orthogonal biochemical methods","pmids":["35491809"],"is_preprint":false},{"year":2023,"finding":"OPTN initiates PINK1/Parkin mitophagy through an unconventional pathway that does not require FIP200 binding or ULK1/2 kinases. Instead, OPTN uses the kinase TBK1, which binds directly to PI3KC3-C1 (class III phosphatidylinositol 3-kinase complex I) to initiate mitophagy. This is mechanistically distinct from NDP52-mediated initiation (which uses FIP200).","method":"Gene-edited cell lines lacking autophagy receptors and upstream initiation factors; in vitro reconstitution of TBK1-PI3KC3-C1 interaction; epistasis analysis of FIP200/ULK1/2 dependence","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution combined with gene-edited cell epistasis and multiple orthogonal approaches in a single study","pmids":["37207627"],"is_preprint":false},{"year":2019,"finding":"PINK1 associates with TRAF3 via its kinase domain and inhibits Parkin-mediated K48-linked TRAF3 proteasomal degradation, thereby positively regulating RLR-triggered innate immune responses. PINK1 also interacts with YAP1 upon viral infection and impairs YAP1/IRF3 complex formation. PINK1 knockdown reduces cytokine production and IRF3/NF-κB activation upon viral infection.","method":"Co-immunoprecipitation of PINK1 with TRAF3 and YAP1; PINK1 knockdown in macrophages; cytokine ELISA; IRF3/NF-κB activation assays; ubiquitylation assays of TRAF3","journal":"Frontiers in immunology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP and knockdown study, single lab, limited mechanistic depth","pmids":["31139191"],"is_preprint":false},{"year":2019,"finding":"PINK1 phosphorylates ubiquitin predominantly in astrocytes rather than neurons under basal and mitochondrial stress conditions, as determined by pS65-ubiquitin western blotting and immunofluorescence in primary cultures of neurons, astrocytes, microglia, and oligodendrocyte progenitor cells from wild-type and PINK1 knockout rats.","method":"pS65-ubiquitin western blotting and immunofluorescence in primary rat brain cell cultures; PINK1 KO comparison; CCCP/valinomycin mitochondrial stress treatment","journal":"NPJ Parkinson's disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct comparison across multiple primary cell types with KO controls using two orthogonal readouts, single lab","pmids":["31840043"],"is_preprint":false},{"year":2023,"finding":"PINK1 recruits PD-L1 to mitochondria for degradation via the mitophagy pathway. ATAD3A disrupts PINK1-dependent mitophagy-mediated PD-L1 degradation; paclitaxel increases ATAD3A expression to restrain PINK1-dependent mitophagy, causing PD-L1 to accumulate on the tumor cell membrane rather than being degraded at mitochondria.","method":"Co-immunoprecipitation; subcellular fractionation of PD-L1; PINK1 knockdown mitophagy assays; ATAD3A overexpression/knockdown; immunotherapy patient cohort correlative imaging","journal":"Cell research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mechanism partially established by Co-IP and fractionation, but detailed mechanistic reconstitution not described; single lab","pmids":["36627348"],"is_preprint":false},{"year":2011,"finding":"PINK1 loss-of-function in substantia nigra dopaminergic neurons (PINK1 knockout mice) causes depolarized mitochondrial membrane potential, mitochondrial fragmentation, and increased basal and H2O2-induced ROS. Wild-type PINK1 overexpression restores mitochondrial membrane potential and morphology; PARK6 disease mutants (G309D, E417G, CΔ145) fail to rescue these defects.","method":"Confocal imaging of mitochondrial membrane potential (ΔΨm) and morphology; ROS measurement in PINK1 KO dopaminergic neurons; PINK1 mutant overexpression rescue","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct imaging and functional assays in primary KO neurons with mutant rescue panel, single lab","pmids":["21421046"],"is_preprint":false},{"year":2013,"finding":"TRAP1 (TNF receptor-associated protein 1) acts downstream of PINK1 to maintain mitochondrial integrity. TRAP1 overexpression rescues Pink1 loss-of-function phenotypes in Drosophila and mitochondrial fragmentation/dysfunction after siRNA-mediated Pink1 silencing in human SH-SY5Y cells, but does not rescue Parkin deficiency phenotypes, placing TRAP1 specifically downstream of PINK1 (and parallel to/upstream of Parkin).","method":"Drosophila genetic epistasis (TRAP1 overexpression in pink1 and park2 mutants); siRNA knockdown of Pink1 in SH-SY5Y with TRAP1 rescue; mitochondrial morphology and function assays","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in Drosophila validated in human cells with defined pathway placement, single lab","pmids":["23525905"],"is_preprint":false},{"year":2018,"finding":"PINK1/Parkin-mediated mitophagy suppresses mtDNA-driven STING inflammatory signaling; in Pink1-/- mice subject to intestinal Gram-negative bacterial infection, mitochondrial antigen presentation and autoimmune mechanisms are engaged, generating cytotoxic mitochondria-specific CD8+ T cells that cause dopaminergic axonal loss and motor impairment reversible by L-DOPA treatment.","method":"Pink1-/- mouse intestinal infection model; CD8+ T cell characterization; dopaminergic axonal density measurement; L-DOPA pharmacological rescue; flow cytometry","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo KO mouse model with multiple mechanistic readouts and pharmacological rescue, single lab","pmids":["31316206"],"is_preprint":false},{"year":2015,"finding":"pS65-ubiquitin (PINK1-phosphorylated ubiquitin) is barely detectable under basal conditions but is rapidly induced upon mitochondrial stress in cells; it is amplified by functional Parkin and is dependent on PINK1 kinase activity as confirmed in patient fibroblasts and postmortem brain samples with pathogenic mutations. pS65-Ub is reversible and accumulates as cytoplasmic granules in aged and diseased human brain.","method":"Novel anti-pS65-Ub antibodies; western blotting and immunofluorescence in cells, primary neurons, patient fibroblasts, and human postmortem brain; genetic confirmation with PINK1 patient mutations","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — validated antibodies, multiple tissue systems including patient material, single lab with multiple orthogonal methods","pmids":["26162776"],"is_preprint":false},{"year":2018,"finding":"The PINK1 p.I368N pathogenic mutation reduces binding to the co-chaperone complex HSP90/CDC37 and abolishes stress-induced interaction with TOM40, preventing PINK1 stabilization on the outer mitochondrial membrane. Structural modeling and functional assays confirm that p.I368N deforms the ATP-binding pocket and abolishes ubiquitin kinase activity.","method":"Patient fibroblast biochemical assays; Co-immunoprecipitation of PINK1 with HSP90/CDC37 and TOM40; structural modeling; ubiquitin kinase activity assays; pS65-Ub western blotting","journal":"Molecular neurodegeneration","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient fibroblast Co-IP, kinase activity assay, and structural analysis, single lab","pmids":["28438176"],"is_preprint":false},{"year":2014,"finding":"smARF (short mitochondrial ARF) depolarizes mitochondria and promotes PINK1/Parkin-dependent mitophagy in both cell lines and neurons, positioning smARF as an intrinsic signaling molecule upstream of PINK1 and Parkin in the mitophagy pathway.","method":"smARF overexpression in cell lines and neurons; Parkin/PINK1 knockdown epistasis; mitochondrial membrane potential measurement; mitophagy flux assays","journal":"The Journal of biological chemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — epistatic knockdown combined with overexpression, mechanism of smARF-to-PINK1 connection not directly established, single lab","pmids":["25217637"],"is_preprint":false},{"year":2023,"finding":"Loss of PINK1 and Parkin leads to dysregulation of IP3R activity, robustly increasing ER calcium release. CISD1 (mitoNEET) functions downstream of Parkin to directly control IP3R. Genetic and pharmacological suppression of CISD1 restores increased ER calcium release in PINK1/Parkin null mammalian cells and flies, and rescues PD-related phenotypes (locomotor defects, dopaminergic neurodegeneration) in Drosophila.","method":"PINK1/Parkin null mammalian cells and Drosophila; CISD1 genetic and pharmacological suppression; ER calcium release measurements; Drosophila locomotor and dopaminergic neuron assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in mammalian cells and Drosophila with functional calcium and neuronal readouts, single lab","pmids":["37626046"],"is_preprint":false}],"current_model":"PINK1 is a mitochondrial outer membrane-localized Ser/Thr kinase that serves as the damage sensor and initiating kinase in the PINK1–Parkin mitophagy pathway: on healthy mitochondria PINK1 is constitutively imported and degraded, but upon mitochondrial depolarization PINK1 accumulates at the TOM–TIM23–VDAC supercomplex (whose cryo-EM structure is now resolved for human PINK1) where it trans-autophosphorylates, undergoes a conformational change to an active state, and phosphorylates Ser65 on ubiquitin and on the Parkin ubiquitin-like domain; phospho-ubiquitin allosterically activates Parkin through a feedforward mechanism involving phospho-Ubl rebinding to the UPD and release of the RING2 catalytic domain; activated Parkin builds K63/K48-ubiquitin chains on outer mitochondrial membrane proteins, recruiting autophagy receptors NDP52 and optineurin (which activate ULK1 and PI3KC3-C1 respectively) to initiate autophagosome formation and mitophagy; beyond mitophagy, PINK1 also regulates ER-phagy via Keap1-dependent ubiquitylation, restrains mtDNA-driven STING innate immune inflammation, controls neuronal Pink1 mRNA localization to mitochondria via SYNJ2BP/SYNJ2 in a metabolic/insulin–AMPK-regulated manner, and modulates IP3R-mediated ER calcium release through the Parkin–CISD1 axis."},"narrative":{"mechanistic_narrative":"PINK1 is a mitochondrial Ser/Thr protein kinase that functions as the damage-sensing, initiating kinase of the PINK1–Parkin mitophagy pathway, controlling the selective autophagic clearance of dysfunctional mitochondria [PMID:20126261, PMID:24751536]. On healthy, polarized mitochondria PINK1 is held at low levels by voltage-dependent proteolysis, but mitochondrial depolarization triggers rapid accumulation of full-length PINK1 on the outer membrane, an event that is necessary and sufficient to recruit Parkin and that places PINK1 genetically upstream of Parkin [PMID:20126261]. Upon stress, PINK1 stabilizes at a TOM–TIM23 supercomplex through an interaction between its N-terminal–C-terminal extension module and the cytosolic domain of Tom20, with the dimeric kinase entering through the TOM40 barrel around a central VDAC2 dimer [PMID:40080546, PMID:38416681]. PINK1 dimerizes and trans-autophosphorylates, undergoing a conformational change to an active ubiquitin-kinase state in which autophosphorylated PINK1 binds substrates with high affinity through a Ub/UBL-binding groove wider than that of conventional kinases [PMID:34933320, PMID:29475881, PMID:29991771]. Active PINK1 phosphorylates ubiquitin and the Parkin ubiquitin-like domain at Ser65; phospho-ubiquitin allosterically activates Parkin via a feedforward mechanism in which phospho-Ubl and phospho-ubiquitin engage distinct sites that release the autoinhibited RING2/RING0 catalytic core [PMID:24751536, PMID:29995846, PMID:35491809]. The resulting ubiquitin signal on damaged mitochondria recruits the autophagy receptors NDP52 and optineurin independently of Parkin, which in turn engage distinct autophagy-initiation machineries—NDP52 via ULK1/FIP200 and optineurin via TBK1–PI3KC3-C1—to nucleate autophagosomes [PMID:26266977, PMID:37207627]. PINK1 stability and activation are governed by an upstream regulatory network including PHB2–PARL–PGAM5, AMBRA1–ATAD3A, TIM23–OMA1, and BNIP3 [PMID:31177901, PMID:34798798, PMID:37160114, PMID:27528605]. Beyond mitophagy, PINK1 restrains mtDNA-driven STING-dependent type I interferon inflammation, whose loss in mice drives dopaminergic neuron loss and motor deficits [PMID:30135585], and neuronal Pink1 mRNA is tethered to mitochondria and locally translated via SYNJ2BP/SYNJ2 under insulin–AMPK metabolic control [PMID:35216662, PMID:38504131]. Pathogenic PINK1 mutations that disrupt mitochondrial accumulation, kinase activity, or ubiquitin phosphorylation are linked to Parkinson's disease and fail to rescue mitochondrial defects in dopaminergic neurons [PMID:21421046, PMID:28438176].","teleology":[{"year":2003,"claim":"Establishing PINK1's basic enzymatic identity was the necessary starting point: it answered whether the gene product is catalytically active at all.","evidence":"recombinant protein in vitro autophosphorylation assay","pmids":["14607334"],"confidence":"Medium","gaps":["No substrate beyond autophosphorylation identified","No subcellular context or pathway placement"]},{"year":2006,"claim":"Localizing PINK1 to mitochondrial membranes in human brain anchored the kinase to the organelle whose quality control it would later be shown to govern.","evidence":"immunohistochemistry, western blotting and subcellular fractionation of human and rat brain","pmids":["16702191"],"confidence":"Medium","gaps":["Membrane sub-topology not resolved","Functional consequence of mitochondrial localization not addressed"]},{"year":2010,"claim":"Defining voltage-dependent PINK1 accumulation as necessary and sufficient for Parkin recruitment established PINK1 as the upstream damage sensor of mitophagy.","evidence":"genetic epistasis with disease mutations, fractionation and live-cell imaging in uncoupler-treated mammalian cells","pmids":["20126261"],"confidence":"High","gaps":["Molecular signal linking depolarization to PINK1 stabilization not defined","Direct PINK1 substrate not yet known"]},{"year":2014,"claim":"Identifying ubiquitin Ser65 as a direct PINK1 substrate solved the central question of how PINK1 activates Parkin, revealing a phospho-ubiquitin feedforward loop.","evidence":"mass spectrometry, in vitro kinase assay with recombinant TcPINK1, cell-free Parkin activation, and phosphomimetic ubiquitin mutants","pmids":["24751536"],"confidence":"High","gaps":["Structural basis of phospho-ubiquitin recognition by Parkin not yet resolved","How autophosphorylation gates substrate phosphorylation unknown"]},{"year":2015,"claim":"Showing PINK1 recruits NDP52 and optineurin independently of Parkin established phospho-ubiquitin as the primary autophagy signal feeding into core autophagy initiation.","evidence":"CRISPR knockout of five autophagy receptors in HeLa cells with imaging and flux assays","pmids":["26266977"],"confidence":"High","gaps":["Distinct initiation machineries used by each receptor not yet defined","In vivo relevance in neurons not tested here"]},{"year":2018,"claim":"Structural and biochemical dissection of PINK1 autophosphorylation and Parkin domain rearrangement defined the molecular logic of substrate recognition and feedforward activation.","evidence":"TcPINK1 crystal structures with ATP analogue, NMR/SAXS/HDX of PINK1–Parkin Ubl, and 1.8 Å crystal structure of phosphorylated parkin with mutagenesis","pmids":["29991771","29475881","29995846"],"confidence":"High","gaps":["Structures used insect/protozoan orthologs rather than human PINK1","Membrane-embedded activation state not captured"]},{"year":2021,"claim":"Capturing the PINK1 dimer mid-trans-autophosphorylation explained how an inactive kinase converts to an active ubiquitin kinase and how it orients on the membrane.","evidence":"crystal and cryo-EM structures of PhPINK1 in unphosphorylated, dimeric, and phosphorylated active states with phosphorylation assays","pmids":["34933320"],"confidence":"High","gaps":["Used Pediculus ortholog, not human PINK1","Context of the TOM complex absent from these structures"]},{"year":2022,"claim":"Mapping two distinct phospho-ubiquitin sites on Parkin clarified how phospho-ubiquitin separately controls Parkin localization and de-repression.","evidence":"ITC, NMR titrations, vinyl-sulfone activity assays and parkin chimera/mutagenesis","pmids":["35491809"],"confidence":"High","gaps":["Kinetic coordination of the two sites in cells not resolved","Relative contributions of pUb versus pUbl in vivo not quantified"]},{"year":2024,"claim":"Demonstrating that PINK1 tethers TOM to TIM23 via its N/C extension–Tom20 interaction defined the supercomplex that holds active PINK1 in place and explained how certain PD mutations block mitophagy.","evidence":"Co-IP and native gels of the PINK1–TOM–TIM23 supercomplex with mutagenesis and mitophagy assays in dopamine neurons and midbrain organoids","pmids":["38416681"],"confidence":"High","gaps":["Atomic detail of the tethering interface not yet resolved here","Stoichiometry within the supercomplex unclear"]},{"year":2025,"claim":"A near-atomic cryo-EM structure of dimeric human PINK1 on an endogenous TOM–VDAC array resolved how PINK1 engages the import machinery, providing a human structural framework for the activation model.","evidence":"3.1 Å cryo-EM of endogenous human PINK1–TOM–VDAC complex with interface mutagenesis and mitophagy assays across cell systems","pmids":["40080546"],"confidence":"High","gaps":["Dynamic transition from import-competent to fully active kinase not captured","Role of VDAC2 dimer in activation not functionally dissected"]},{"year":2024,"claim":"Linking SYNJ2BP/SYNJ2-mediated Pink1 mRNA tethering to insulin–AMPK signaling placed PINK1 production and activation under metabolic control, particularly in neurites.","evidence":"RNA-FISH/live imaging, RNA-IP, SYNJ2BP PDZ phospho-site mutagenesis and PINK1 kinase activity assays in neurons","pmids":["35216662","38504131"],"confidence":"High","gaps":["Mechanism coupling mRNA release to kinase activation incompletely defined","In vivo contribution to neurodegeneration not established"]},{"year":2018,"claim":"Identifying STING-driven inflammation as the consequence of PINK1/Parkin loss extended PINK1's role beyond organelle turnover to innate immune restraint relevant to neurodegeneration.","evidence":"Pink1-/- and Prkn-/- mouse models with mtDNA-mutator and exercise stress, rescued by STING knockout","pmids":["30135585"],"confidence":"High","gaps":["Molecular trigger of mtDNA release in PINK1-deficient cells not defined","Direct PINK1 substrate in this axis unknown"]},{"year":null,"claim":"How the diverse non-canonical PINK1 functions—ER-phagy via Keap1, IP3R/ER calcium via CISD1, TUFm phosphoswitch, and cytoplasmic mTORC2/AKT signaling—are integrated with the core mitophagy program, and whether they share the same activation logic, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["Several non-canonical roles rest on single-lab Co-IP/overexpression studies","No unifying mechanism connecting canonical and non-canonical PINK1 activities"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,3,27]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,8,23]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[9]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,6,7,20]}],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[0,2,30]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,36]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[6,7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[34,38]}],"complexes":["PINK1–TOM–TIM23 supercomplex","TOM–VDAC array"],"partners":["PARK2","TOMM20","TOMM40","VDAC2","PHB2","AMBRA1","ATAD3A","BNIP3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9BXM7","full_name":"Serine/threonine-protein kinase PINK1, mitochondrial","aliases":["BRPK","PTEN-induced putative kinase protein 1"],"length_aa":581,"mass_kda":62.8,"function":"Serine/threonine-protein kinase which acts as a sensor of mitochondrial damage and protects against mitochondrial dysfunction during cellular stress (PubMed:40080546). It phosphorylates mitochondrial proteins to coordinate mitochondrial quality control mechanisms that remove and replace dysfunctional mitochondrial components (PubMed:14607334, PubMed:15087508, PubMed:18443288, PubMed:18957282, PubMed:19229105, PubMed:19966284, PubMed:20404107, PubMed:20547144, PubMed:20798600, PubMed:22396657, PubMed:23620051, PubMed:23754282, PubMed:23933751, PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:24896179, PubMed:24898855, PubMed:25527291, PubMed:32484300). In healthy mitochondria, PINK1 is translocated across the mitochondrial outer membrane (MOM) via the translocase of the outer membrane (TOM) complex, and inserted into the mitochondrial inner membrane (MIM) via the translocase of the inner membrane (TIM23) complex where it is cleaved and released into the cytosol (PubMed:40080546). Depending on the severity of mitochondrial damage, activity ranges from preventing apoptosis and stimulating mitochondrial biogenesis to eliminating severely damaged mitochondria via PINK1-PRKN-dependent mitophagy (PubMed:14607334, PubMed:15087508, PubMed:18443288, PubMed:19966284, PubMed:20404107, PubMed:20798600, PubMed:22396657, PubMed:23620051, PubMed:23933751, PubMed:24898855, PubMed:32047033, PubMed:32484300). When cellular stress results in irreversible mitochondrial damage, PINK1 accumulates at the outer mitochondrial membrane (OMM) where it phosphorylates pre-existing polyubiquitin chains at 'Ser-65', recruits PRKN from the cytosol to the OMM and activates PRKN by phosphorylation at 'Ser-65'; activated PRKN then ubiquitinates VDAC1 and other OMM proteins to initiate mitophagy (PubMed:14607334, PubMed:15087508, PubMed:19966284, PubMed:20404107, PubMed:20798600, PubMed:23754282, PubMed:23933751, PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:25474007, PubMed:25527291, PubMed:32047033, PubMed:40080546). The PINK1-PRKN pathway also promotes fission of damaged mitochondria through phosphorylation and PRKN-dependent degradation of mitochondrial proteins involved in fission such as MFN2 (PubMed:18443288, PubMed:23620051, PubMed:24898855). This prevents the refusion of unhealthy mitochondria with the mitochondrial network or initiates mitochondrial fragmentation facilitating their later engulfment by autophagosomes (PubMed:18443288, PubMed:23620051). Also promotes mitochondrial fission independently of PRKN and ATG7-mediated mitophagy, via the phosphorylation and activation of DNM1L (PubMed:18443288, PubMed:32484300). Regulates motility of damaged mitochondria by promoting the ubiquitination and subsequent degradation of MIRO1 and MIRO2; in motor neurons, this likely inhibits mitochondrial intracellular anterograde transport along the axons which probably increases the chance of the mitochondria undergoing mitophagy in the soma (PubMed:22396657). Required for ubiquinone reduction by mitochondrial complex I by mediating phosphorylation of complex I subunit NDUFA10 (By similarity). Phosphorylates LETM1, positively regulating its mitochondrial calcium transport activity (PubMed:29123128)","subcellular_location":"Mitochondrion outer membrane; Mitochondrion inner membrane; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q9BXM7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PINK1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PINK1","total_profiled":1310},"omim":[{"mim_id":"617221","title":"HEXOKINASE DOMAIN-CONTAINING PROTEIN 1; HKDC1","url":"https://www.omim.org/entry/617221"},{"mim_id":"617081","title":"OMA1 ZINC METALLOPEPTIDASE; OMA1","url":"https://www.omim.org/entry/617081"},{"mim_id":"616840","title":"PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23","url":"https://www.omim.org/entry/616840"},{"mim_id":"615609","title":"SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 3; SIAH3","url":"https://www.omim.org/entry/615609"},{"mim_id":"613888","title":"RAS HOMOLOG GENE FAMILY, MEMBER T1; RHOT1","url":"https://www.omim.org/entry/613888"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":358.8},{"tissue":"tongue","ntpm":366.6}],"url":"https://www.proteinatlas.org/search/PINK1"},"hgnc":{"alias_symbol":["BRPK"],"prev_symbol":["PARK6"]},"alphafold":{"accession":"Q9BXM7","domains":[{"cath_id":"3.30.200.20","chopping":"145-179_214-321","consensus_level":"medium","plddt":86.6131,"start":145,"end":321}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BXM7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BXM7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BXM7-F1-predicted_aligned_error_v6.png","plddt_mean":77.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PINK1","jax_strain_url":"https://www.jax.org/strain/search?query=PINK1"},"sequence":{"accession":"Q9BXM7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BXM7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BXM7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BXM7"}},"corpus_meta":[{"pmid":"20126261","id":"PMC_20126261","title":"PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.","date":"2010","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/20126261","citation_count":2405,"is_preprint":false},{"pmid":"26266977","id":"PMC_26266977","title":"The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26266977","citation_count":2290,"is_preprint":false},{"pmid":"23620051","id":"PMC_23620051","title":"PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria.","date":"2013","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23620051","citation_count":1080,"is_preprint":false},{"pmid":"30135585","id":"PMC_30135585","title":"Parkin and PINK1 mitigate STING-induced inflammation.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30135585","citation_count":1074,"is_preprint":false},{"pmid":"24751536","id":"PMC_24751536","title":"PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity.","date":"2014","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24751536","citation_count":1052,"is_preprint":false},{"pmid":"19279012","id":"PMC_19279012","title":"Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19279012","citation_count":811,"is_preprint":false},{"pmid":"27291334","id":"PMC_27291334","title":"Deciphering the Molecular Signals of PINK1/Parkin Mitophagy.","date":"2016","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27291334","citation_count":593,"is_preprint":false},{"pmid":"25562319","id":"PMC_25562319","title":"PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/25562319","citation_count":521,"is_preprint":false},{"pmid":"25697963","id":"PMC_25697963","title":"PINK1/Parkin-mediated mitophagy in mammalian cells.","date":"2015","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25697963","citation_count":494,"is_preprint":false},{"pmid":"33168089","id":"PMC_33168089","title":"PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.","date":"2020","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/33168089","citation_count":387,"is_preprint":false},{"pmid":"31316206","id":"PMC_31316206","title":"Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31316206","citation_count":382,"is_preprint":false},{"pmid":"31177901","id":"PMC_31177901","title":"PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31177901","citation_count":342,"is_preprint":false},{"pmid":"21606348","id":"PMC_21606348","title":"PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21606348","citation_count":333,"is_preprint":false},{"pmid":"29995846","id":"PMC_29995846","title":"Mechanism of parkin activation by PINK1.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29995846","citation_count":318,"is_preprint":false},{"pmid":"24735649","id":"PMC_24735649","title":"Parkin and PINK1: much more than mitophagy.","date":"2014","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/24735649","citation_count":316,"is_preprint":false},{"pmid":"39358449","id":"PMC_39358449","title":"The role of PINK1-Parkin in mitochondrial quality control.","date":"2024","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/39358449","citation_count":305,"is_preprint":false},{"pmid":"21194381","id":"PMC_21194381","title":"Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control.","date":"2011","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21194381","citation_count":298,"is_preprint":false},{"pmid":"36503124","id":"PMC_36503124","title":"PINK1/Parkin-mediated mitophagy in neurodegenerative diseases.","date":"2022","source":"Ageing research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/36503124","citation_count":291,"is_preprint":false},{"pmid":"28437683","id":"PMC_28437683","title":"PINK1 and Parkin: emerging themes in mitochondrial homeostasis.","date":"2017","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28437683","citation_count":275,"is_preprint":false},{"pmid":"16702191","id":"PMC_16702191","title":"PINK1 protein in normal human brain and Parkinson's disease.","date":"2006","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16702191","citation_count":268,"is_preprint":false},{"pmid":"27094585","id":"PMC_27094585","title":"Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond.","date":"2016","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27094585","citation_count":265,"is_preprint":false},{"pmid":"29325568","id":"PMC_29325568","title":"PINK1 import regulation; a fine system to convey mitochondrial stress to the cytosol.","date":"2018","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29325568","citation_count":254,"is_preprint":false},{"pmid":"27528605","id":"PMC_27528605","title":"BNIP3 Protein Suppresses PINK1 Kinase Proteolytic Cleavage to Promote Mitophagy.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27528605","citation_count":237,"is_preprint":false},{"pmid":"30100261","id":"PMC_30100261","title":"PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism.","date":"2018","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/30100261","citation_count":224,"is_preprint":false},{"pmid":"29809156","id":"PMC_29809156","title":"Deficiency of parkin and PINK1 impairs age-dependent mitophagy in Drosophila.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29809156","citation_count":176,"is_preprint":false},{"pmid":"12447943","id":"PMC_12447943","title":"Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study.","date":"2002","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12447943","citation_count":162,"is_preprint":false},{"pmid":"17141510","id":"PMC_17141510","title":"Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.","date":"2006","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/17141510","citation_count":159,"is_preprint":false},{"pmid":"34933320","id":"PMC_34933320","title":"Activation mechanism of PINK1.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34933320","citation_count":157,"is_preprint":false},{"pmid":"21187721","id":"PMC_21187721","title":"Regulation of PINK1-Parkin-mediated mitophagy.","date":"2011","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/21187721","citation_count":154,"is_preprint":false},{"pmid":"26162776","id":"PMC_26162776","title":"(Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation.","date":"2015","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/26162776","citation_count":153,"is_preprint":false},{"pmid":"27334109","id":"PMC_27334109","title":"The PINK1, synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27334109","citation_count":146,"is_preprint":false},{"pmid":"19276113","id":"PMC_19276113","title":"FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19276113","citation_count":139,"is_preprint":false},{"pmid":"28017782","id":"PMC_28017782","title":"Parkin and PINK1 functions in oxidative stress and neurodegeneration.","date":"2016","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/28017782","citation_count":125,"is_preprint":false},{"pmid":"35216662","id":"PMC_35216662","title":"Neuronal mitochondria transport Pink1 mRNA via synaptojanin 2 to support local mitophagy.","date":"2022","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/35216662","citation_count":118,"is_preprint":false},{"pmid":"19967438","id":"PMC_19967438","title":"The PINK1/Parkin pathway: a mitochondrial quality control system?","date":"2009","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/19967438","citation_count":116,"is_preprint":false},{"pmid":"31982458","id":"PMC_31982458","title":"The PINK1-Parkin axis: An Overview.","date":"2020","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/31982458","citation_count":115,"is_preprint":false},{"pmid":"20049715","id":"PMC_20049715","title":"PINK1 function in health and disease.","date":"2009","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20049715","citation_count":115,"is_preprint":false},{"pmid":"21177249","id":"PMC_21177249","title":"A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21177249","citation_count":110,"is_preprint":false},{"pmid":"27586587","id":"PMC_27586587","title":"Mitochondrial quality control by the Pink1/Parkin system.","date":"2016","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/27586587","citation_count":108,"is_preprint":false},{"pmid":"36627348","id":"PMC_36627348","title":"Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria.","date":"2023","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36627348","citation_count":102,"is_preprint":false},{"pmid":"21421046","id":"PMC_21421046","title":"PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21421046","citation_count":100,"is_preprint":false},{"pmid":"29475881","id":"PMC_29475881","title":"PINK1 autophosphorylation is required for ubiquitin recognition.","date":"2018","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/29475881","citation_count":100,"is_preprint":false},{"pmid":"37207627","id":"PMC_37207627","title":"Unconventional initiation of PINK1/Parkin mitophagy by Optineurin.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37207627","citation_count":96,"is_preprint":false},{"pmid":"30386443","id":"PMC_30386443","title":"PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses.","date":"2018","source":"Inflammation and regeneration","url":"https://pubmed.ncbi.nlm.nih.gov/30386443","citation_count":94,"is_preprint":false},{"pmid":"31254044","id":"PMC_31254044","title":"Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond.","date":"2019","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/31254044","citation_count":92,"is_preprint":false},{"pmid":"32805222","id":"PMC_32805222","title":"PINK1: The guard of mitochondria.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32805222","citation_count":90,"is_preprint":false},{"pmid":"27754761","id":"PMC_27754761","title":"A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis.","date":"2016","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/27754761","citation_count":87,"is_preprint":false},{"pmid":"23533695","id":"PMC_23533695","title":"Function and characteristics of PINK1 in mitochondria.","date":"2013","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/23533695","citation_count":81,"is_preprint":false},{"pmid":"28507507","id":"PMC_28507507","title":"PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28507507","citation_count":80,"is_preprint":false},{"pmid":"27251035","id":"PMC_27251035","title":"The mitochondrial kinase PINK1: functions beyond mitophagy.","date":"2016","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27251035","citation_count":79,"is_preprint":false},{"pmid":"23525905","id":"PMC_23525905","title":"TRAP1 rescues PINK1 loss-of-function phenotypes.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23525905","citation_count":79,"is_preprint":false},{"pmid":"34717133","id":"PMC_34717133","title":"PTEN-induced kinase 1 (PINK1) and Parkin: Unlocking a mitochondrial quality control pathway linked to Parkinson's disease.","date":"2021","source":"Current opinion in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/34717133","citation_count":75,"is_preprint":false},{"pmid":"31577952","id":"PMC_31577952","title":"PINK1/Parkin Influences Cell Cycle by Sequestering TBK1 at Damaged Mitochondria, Inhibiting Mitosis.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31577952","citation_count":75,"is_preprint":false},{"pmid":"34823575","id":"PMC_34823575","title":"PINK1 deficiency impairs osteoblast differentiation through aberrant mitochondrial homeostasis.","date":"2021","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34823575","citation_count":71,"is_preprint":false},{"pmid":"21784538","id":"PMC_21784538","title":"Genetic mutations and functions of PINK1.","date":"2011","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21784538","citation_count":70,"is_preprint":false},{"pmid":"34798798","id":"PMC_34798798","title":"AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/34798798","citation_count":69,"is_preprint":false},{"pmid":"27906179","id":"PMC_27906179","title":"PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control.","date":"2016","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/27906179","citation_count":68,"is_preprint":false},{"pmid":"27701735","id":"PMC_27701735","title":"PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease.","date":"2016","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27701735","citation_count":66,"is_preprint":false},{"pmid":"28438176","id":"PMC_28438176","title":"The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity.","date":"2017","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/28438176","citation_count":66,"is_preprint":false},{"pmid":"38416681","id":"PMC_38416681","title":"Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38416681","citation_count":63,"is_preprint":false},{"pmid":"25450579","id":"PMC_25450579","title":"PINK1 signalling in cancer biology.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25450579","citation_count":57,"is_preprint":false},{"pmid":"33113344","id":"PMC_33113344","title":"Paradoxical Mitophagy Regulation by PINK1 and TUFm.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33113344","citation_count":55,"is_preprint":false},{"pmid":"14607334","id":"PMC_14607334","title":"BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential.","date":"2003","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/14607334","citation_count":54,"is_preprint":false},{"pmid":"34800266","id":"PMC_34800266","title":"PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis.","date":"2021","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/34800266","citation_count":51,"is_preprint":false},{"pmid":"22687462","id":"PMC_22687462","title":"Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders.","date":"2012","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22687462","citation_count":49,"is_preprint":false},{"pmid":"37633267","id":"PMC_37633267","title":"PINK1, Keap1, and Rtnl1 regulate selective clearance of endoplasmic reticulum during development.","date":"2023","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/37633267","citation_count":48,"is_preprint":false},{"pmid":"37054910","id":"PMC_37054910","title":"Structural Mechanisms of Mitochondrial Quality Control Mediated by PINK1 and Parkin.","date":"2023","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/37054910","citation_count":48,"is_preprint":false},{"pmid":"28962651","id":"PMC_28962651","title":"Hexokinases link DJ-1 to the PINK1/parkin pathway.","date":"2017","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/28962651","citation_count":47,"is_preprint":false},{"pmid":"40080546","id":"PMC_40080546","title":"Structure of human PINK1 at a mitochondrial TOM-VDAC array.","date":"2025","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/40080546","citation_count":44,"is_preprint":false},{"pmid":"37626046","id":"PMC_37626046","title":"PINK1 and Parkin regulate IP3R-mediated ER calcium release.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37626046","citation_count":44,"is_preprint":false},{"pmid":"32297878","id":"PMC_32297878","title":"PINK1 and Parkin: team players in stress-induced mitophagy.","date":"2020","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32297878","citation_count":43,"is_preprint":false},{"pmid":"35184140","id":"PMC_35184140","title":"PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35184140","citation_count":43,"is_preprint":false},{"pmid":"33919398","id":"PMC_33919398","title":"PINK1: A Bridge between Mitochondria and Parkinson's Disease.","date":"2021","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33919398","citation_count":42,"is_preprint":false},{"pmid":"28647367","id":"PMC_28647367","title":"Mitochondrial quality control pathways: PINK1 acts as a gatekeeper.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28647367","citation_count":41,"is_preprint":false},{"pmid":"31840043","id":"PMC_31840043","title":"PINK1 phosphorylates ubiquitin predominantly in astrocytes.","date":"2019","source":"NPJ Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/31840043","citation_count":41,"is_preprint":false},{"pmid":"19595762","id":"PMC_19595762","title":"Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19595762","citation_count":41,"is_preprint":false},{"pmid":"25670069","id":"PMC_25670069","title":"DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating Pink1.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/25670069","citation_count":41,"is_preprint":false},{"pmid":"37160114","id":"PMC_37160114","title":"TIM23 facilitates PINK1 activation by safeguarding against OMA1-mediated degradation in damaged mitochondria.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37160114","citation_count":40,"is_preprint":false},{"pmid":"25553463","id":"PMC_25553463","title":"Functions and characteristics of PINK1 and Parkin in cancer.","date":"2015","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/25553463","citation_count":38,"is_preprint":false},{"pmid":"28259921","id":"PMC_28259921","title":"High expression of PINK1 promotes proliferation and chemoresistance of NSCLC.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28259921","citation_count":38,"is_preprint":false},{"pmid":"24751806","id":"PMC_24751806","title":"Loss of PINK1 impairs stress-induced autophagy and cell survival.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24751806","citation_count":38,"is_preprint":false},{"pmid":"29991771","id":"PMC_29991771","title":"Structural insights into ubiquitin phosphorylation by PINK1.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29991771","citation_count":36,"is_preprint":false},{"pmid":"28361482","id":"PMC_28361482","title":"Induction of PINK1/Parkin-Mediated Mitophagy.","date":"2018","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/28361482","citation_count":35,"is_preprint":false},{"pmid":"25700839","id":"PMC_25700839","title":"Molecular mechanisms underlying PINK1 and Parkin catalyzed ubiquitylation of substrates on damaged mitochondria.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25700839","citation_count":35,"is_preprint":false},{"pmid":"39972141","id":"PMC_39972141","title":"Dual regulation of mitochondrial fusion by Parkin-PINK1 and OMA1.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/39972141","citation_count":34,"is_preprint":false},{"pmid":"20045449","id":"PMC_20045449","title":"Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress.","date":"2010","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20045449","citation_count":34,"is_preprint":false},{"pmid":"38504131","id":"PMC_38504131","title":"Insulin signalling regulates Pink1 mRNA localization via modulation of AMPK activity to support PINK1 function in neurons.","date":"2024","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38504131","citation_count":33,"is_preprint":false},{"pmid":"32157382","id":"PMC_32157382","title":"N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.","date":"2020","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32157382","citation_count":33,"is_preprint":false},{"pmid":"36071695","id":"PMC_36071695","title":"The emerging multifaceted role of PINK1 in cancer biology.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/36071695","citation_count":33,"is_preprint":false},{"pmid":"22644621","id":"PMC_22644621","title":"Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1).","date":"2012","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/22644621","citation_count":33,"is_preprint":false},{"pmid":"15349859","id":"PMC_15349859","title":"The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism.","date":"2004","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15349859","citation_count":32,"is_preprint":false},{"pmid":"17172567","id":"PMC_17172567","title":"PINK1 mutation heterozygosity and the risk of Parkinson's disease.","date":"2007","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17172567","citation_count":32,"is_preprint":false},{"pmid":"34077728","id":"PMC_34077728","title":"PINK1 and parkin shape the organism-wide distribution of a deleterious mitochondrial genome.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34077728","citation_count":32,"is_preprint":false},{"pmid":"16701203","id":"PMC_16701203","title":"Parkin blushed by PINK1.","date":"2006","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/16701203","citation_count":31,"is_preprint":false},{"pmid":"27959386","id":"PMC_27959386","title":"PINK1 signaling in mitochondrial homeostasis and in aging (Review).","date":"2016","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27959386","citation_count":31,"is_preprint":false},{"pmid":"35491809","id":"PMC_35491809","title":"Structural basis for feedforward control in the PINK1/Parkin pathway.","date":"2022","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/35491809","citation_count":31,"is_preprint":false},{"pmid":"31139191","id":"PMC_31139191","title":"Mitochondrial Protein PINK1 Positively Regulates RLR Signaling.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31139191","citation_count":30,"is_preprint":false},{"pmid":"25217637","id":"PMC_25217637","title":"Short mitochondrial ARF triggers Parkin/PINK1-dependent mitophagy.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25217637","citation_count":29,"is_preprint":false},{"pmid":"39000117","id":"PMC_39000117","title":"Canagliflozin Mitigates Diabetic Cardiomyopathy through Enhanced PINK1-Parkin Mitophagy.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39000117","citation_count":28,"is_preprint":false},{"pmid":"37334901","id":"PMC_37334901","title":"PARK15/FBXO7 is dispensable for PINK1/Parkin mitophagy in iNeurons and HeLa cell systems.","date":"2023","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/37334901","citation_count":27,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44480,"output_tokens":11589,"usd":0.153638,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22790,"output_tokens":4434,"usd":0.1124,"stage2_stop_reason":"end_turn"},"total_usd":0.266038,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"PINK1 accumulation on mitochondria is regulated by voltage-dependent proteolysis: on healthy, polarized mitochondria PINK1 is kept at low levels, while mitochondrial damage (depolarization) causes rapid accumulation of full-length PINK1 on the outer mitochondrial membrane. PINK1 accumulation is both necessary and sufficient for Parkin recruitment to mitochondria, and PINK1 acts upstream of Parkin in the mitophagy pathway.\",\n      \"method\": \"Genetic epistasis (disease-causing mutations dissecting pathway steps), biochemical fractionation, fluorescence microscopy of mitochondrial PINK1 and Parkin localization in mammalian cells with uncoupler treatment\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal epistasis analysis combined with biochemical fractionation and live-cell imaging, replicated across multiple subsequent studies\",\n      \"pmids\": [\"20126261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PINK1 directly phosphorylates ubiquitin at Ser65, homologous to Ser65 in the Parkin ubiquitin-like domain. Phospho-ubiquitin (pS65-Ub) activates Parkin E3 ubiquitin ligase activity in cell-free assays, and the phosphomimetic ubiquitin S65D binds and activates Parkin. Expression of non-phosphorylatable ubiquitin S65A inhibits Parkin translocation to damaged mitochondria, establishing a feed-forward activation mechanism.\",\n      \"method\": \"Mass spectrometry identification of endogenous phosphorylation site; in vitro kinase assay with recombinant TcPINK1 and ubiquitin; cell-free Parkin activation assay; phosphomimetic/phospho-dead ubiquitin mutant overexpression in cells\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified components, mass spectrometry identification, mutagenesis, independently replicated by multiple labs\",\n      \"pmids\": [\"24751536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PINK1 recruits autophagy receptors NDP52 and optineurin (but not p62) to mitochondria independently of Parkin to initiate mitophagy. Once recruited, NDP52 and optineurin recruit autophagy initiation factors ULK1, DFCP1, and WIPI1 to focal spots proximal to mitochondria upstream of LC3, placing PINK1-generated phospho-ubiquitin as the primary autophagy signal on mitochondria.\",\n      \"method\": \"CRISPR/Cas9 knockout of five autophagy receptors in HeLa cells; fluorescence imaging of receptor recruitment; epistasis analysis of receptor dependence for mitophagy flux\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-edited knockout cells with multiple receptor knockouts, orthogonal imaging and flux assays, single rigorous study with strong controls\",\n      \"pmids\": [\"26266977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PINK1 phosphorylates mitofusin 2 (Mfn2) on the mitochondrial outer membrane, and phospho-Mfn2 acts as a receptor for Parkin. Parkin binds Mfn2 in a PINK1-dependent manner and promotes its ubiquitination. Ablation of Mfn2 in mouse cardiomyocytes prevents depolarization-induced Parkin translocation to mitochondria and suppresses mitophagy.\",\n      \"method\": \"Co-immunoprecipitation; PINK1 in vitro phosphorylation assay with Mfn2; conditional cardiac Mfn2 knockout mice; mitophagy assays\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and in vitro phosphorylation plus KO mouse model, single lab; subsequent work questions universality of this receptor\",\n      \"pmids\": [\"23620051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The mechanism of Parkin activation by PINK1 involves large-scale domain rearrangement: phospho-Ubl (phosphorylated by PINK1 at Ser65) rebinds to the parkin core at the unique parkin domain (UPD) and releases the catalytic RING2 domain from autoinhibition. A conserved linker ACT element between Ubl and UPD mimics RING2 interactions to facilitate release. Crystal structure of phosphorylated human parkin at 1.8 Å reveals the phospho-Ubl binding site on UPD lined by AR-JP disease mutations.\",\n      \"method\": \"Hydrogen-deuterium exchange mass spectrometry of full-length human parkin during activation; 1.8 Å crystal structure of phosphorylated human parkin; structure-guided mutagenesis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with HDX-MS and mutagenesis in a single rigorous study providing direct mechanistic insight\",\n      \"pmids\": [\"29995846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PINK1 is activated through a multi-step mechanism involving: (1) dimerization and trans-autophosphorylation captured in a cryo-EM structure of a symmetric PhPINK1 dimer; (2) conformational change upon autophosphorylation to an active ubiquitin kinase state; (3) an N-terminal helix orienting unphosphorylated PINK1 on the mitochondrial outer membrane. Regulatory oxidation of PINK1 also modulates its activity.\",\n      \"method\": \"Crystallography of unphosphorylated PhPINK1; cryo-EM structures of PhPINK1 dimer during trans-autophosphorylation and of phosphorylated active state; in vitro phosphorylation assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple crystal and cryo-EM structures combined with biochemical phosphorylation assays in a single comprehensive study\",\n      \"pmids\": [\"34933320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structure at 3.1 Å resolution of dimeric human PINK1 stabilized at an endogenous TOM-VDAC array reveals: PINK1 enters mitochondria through the proximal TOM40 barrel guided by TOM7 and TOM22; TOM5 and TOM20 both bind PINK1 kinase C-lobes; a symmetric arrangement of two TOM core complexes around a central VDAC2 dimer is facilitated by TOM5 and TOM20. The N-terminal–C-terminal extension module of PINK1 interacts with the cytosolic domain of Tom20 to stabilize PINK1 at the TOM complex.\",\n      \"method\": \"3.1 Å cryo-EM structure of endogenous human PINK1–TOM–VDAC complex; mutagenesis of PINK1–Tom20 interaction interface; mitophagy functional assays in cell lines, dopamine neurons, and midbrain organoids\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — near-atomic cryo-EM structure combined with mutagenesis and functional validation in multiple cell systems\",\n      \"pmids\": [\"40080546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Upon mitochondrial stress, PINK1 induces formation of a PINK1–TOM–TIM23 supercomplex in human cell lines, dopamine neurons, and midbrain organoids. PINK1 is required to stably tether TOM to TIM23; this tethering depends on an interaction between the PINK1 N-terminal–C-terminal extension module and the cytosolic domain of Tom20. Disruption of this interaction by designer or PD-associated PINK1 mutations inhibits downstream mitophagy.\",\n      \"method\": \"Co-immunoprecipitation and native gel electrophoresis of PINK1–TOM–TIM23 supercomplex; mutagenesis of PINK1 N-terminal module; mitophagy assays in dopamine neurons and midbrain organoids\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP establishing supercomplex, mutagenesis, functional validation in multiple physiologically relevant systems\",\n      \"pmids\": [\"38416681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PINK1 autophosphorylation (at Ser205 in TcPINK1, equivalent to Ser228 in human PINK1) is required for substrate recognition; autophosphorylated PINK1 binds the Parkin Ubl domain with ~10-fold higher affinity than ubiquitin via a conserved interface. Multiple PINK1 molecules autophosphorylate in trans prior to binding and phosphorylating ubiquitin and Parkin.\",\n      \"method\": \"Enzyme kinetics; NMR spectroscopy of PINK1–Parkin Ubl interaction; mass spectrometry mapping of autophosphorylation site; SAXS; hydrogen-deuterium exchange\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR, enzyme kinetics, mass spectrometry, and SAXS in a single study with rigorous biochemical characterization\",\n      \"pmids\": [\"29475881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Structural analysis of TcPINK1 kinase domain with non-hydrolyzable ATP analogue at 2.5 Å reveals a Ub/UBL-binding groove wider than the peptide-binding groove of PKA/PKC to accommodate the globular Ub/UBL head; crosslinking and structure-guided mutagenesis identified the PINK1-interacting surface on ubiquitin.\",\n      \"method\": \"2.5 Å crystal structure of TcPINK1–ATP analogue complex; crosslinking mass spectrometry; structure-guided mutagenesis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure combined with crosslinking and mutagenesis providing direct structural insight into substrate binding\",\n      \"pmids\": [\"29991771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PINK1 autophosphorylation in Drosophila at Ser346 (identified by LC-MS/MS) is required for Parkin mitochondrial recruitment and for PINK1 kinase activity toward Parkin. Phosphorylation of Parkin by PINK1 is dispensable for Parkin translocation but required for Parkin activation. Autophosphorylation-deficient PINK1 fails to rescue pink1 null phenotypes.\",\n      \"method\": \"LC-MS/MS mapping of Drosophila PINK1 autophosphorylation; site-directed mutagenesis; Drosophila photoreceptor neuron degeneration model; mitochondrial Parkin recruitment assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mass spectrometry site identification with mutagenesis and functional rescue in Drosophila model, single lab\",\n      \"pmids\": [\"27906179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PHB2 (inner mitochondrial membrane scaffold protein) stabilizes PINK1 on mitochondria; PHB2 depletion destabilizes PINK1, blocking Parkin/ubiquitin/OPTN recruitment and inhibiting mitophagy. PHB2 interacts with and inhibits the PARL protease; upon PHB2 depletion, PARL is activated and processes PGAM5, reducing PINK1 stability. Thus PHB2-PARL-PGAM5 constitutes a novel upstream regulatory axis for PINK1 stabilization.\",\n      \"method\": \"Co-immunoprecipitation of PHB2 with PARL; siRNA knockdown of PHB2, PARL, PGAM5; immunofluorescence of PINK1, Parkin, ubiquitin, OPTN mitochondrial recruitment; overexpression rescue experiments\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and multiple knockdown experiments with defined phenotypic readouts, single lab\",\n      \"pmids\": [\"31177901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AMBRA1 is recruited to the outer mitochondrial membrane upon mitochondrial depolarization and interacts with PINK1 and ATAD3A (a transmembrane protein mediating PINK1 import and degradation). AMBRA1 downregulation reduces PINK1 levels via enhanced LONP1 protease-dependent degradation, decreasing PINK1-mediated ubiquitin phosphorylation and Parkin recruitment. ATAD3A silencing rescues defective PINK1 accumulation in AMBRA1-deficient cells.\",\n      \"method\": \"Co-immunoprecipitation of AMBRA1 with PINK1 and ATAD3A; siRNA knockdown of AMBRA1, ATAD3A, LONP1; immunoblotting of pS65-Ub and Parkin recruitment; mitophagy flux assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and epistatic knockdown analysis with defined readouts, single lab\",\n      \"pmids\": [\"34798798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TIM23 (inner mitochondrial membrane translocase subunit) is identified by mass spectrometry as a component of the PINK1 complex. TIM23 downregulation decreases PINK1 levels and delays PINK1 autophosphorylation upon depolarization. TIM23 protects PINK1 from degradation by the mitochondrial protease OMA1; OMA1 inactivation rescues PINK1 accumulation defects caused by TIM23 downregulation and partially restores pathogenic PINK1 mutants that fail to interact with TIM23.\",\n      \"method\": \"Mass spectrometry of PINK1 co-immunoprecipitates; siRNA knockdown of TIM23 and OMA1; PINK1 autophosphorylation kinetics; co-immunoprecipitation of TIM23-PINK1\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mass spectrometry identification confirmed by Co-IP, epistatic knockdown analysis with kinetic readouts, single lab\",\n      \"pmids\": [\"37160114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BNIP3 interacts with PINK1 at the outer mitochondrial membrane, suppresses PINK1 proteolytic cleavage, promotes accumulation of full-length PINK1, and thereby facilitates Parkin recruitment and PINK1/Parkin-mediated mitophagy. Inactivation of BNIP3 promotes PINK1 proteolytic processing and suppresses mitophagy. Hypoxia-induced BNIP3 expression increases full-length PINK1 levels.\",\n      \"method\": \"Co-immunoprecipitation of BNIP3 and PINK1; BNIP3 siRNA knockdown and overexpression; Parkin recruitment assays; Drosophila rescue experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with functional knockdown/overexpression validation and in vivo Drosophila confirmation, single lab\",\n      \"pmids\": [\"27528605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PINK1 and Parkin influence the cell cycle by sequestering TBK1 at damaged mitochondria during mitophagy, thereby preventing TBK1 from performing its physiological role at centrosomes during mitosis. Loss of PINK1 and Parkin accelerates cell growth.\",\n      \"method\": \"Genetic interaction screen; TBK1 localization imaging at centrosomes vs. mitochondria; PINK1/Parkin loss-of-function cell proliferation assays; epistasis analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis and subcellular localization with functional proliferation readout, single lab\",\n      \"pmids\": [\"31577952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of PINK1 and Parkin leads to mtDNA-driven STING-dependent type I interferon inflammation in mice. PINK1/Parkin-mediated mitophagy restrains innate immunity by preventing release of mitochondrial DAMPs; concurrent loss of STING completely rescues inflammation, dopaminergic neuron loss, and motor defects in aged Prkn-/-;mutator mice.\",\n      \"method\": \"Pink1-/- and Prkn-/- mouse models with exhaustive exercise and mtDNA mutator backgrounds; genetic rescue by STING knockout; cytokine measurement; dopaminergic neuron quantification\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double/triple knockout mouse models, multiple orthogonal phenotypic readouts, single rigorous study\",\n      \"pmids\": [\"30135585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PINK1 knockdown in SH-SY5Y cells induces mitochondrial fragmentation and mitophagy driven by mitochondrial ROS. Dominant-negative Drp1 inhibits both fission and mitophagy in PINK1-deficient cells, placing Drp1-dependent fission upstream of mitophagy in the PINK1 pathway. Overexpression of wild-type PINK1 suppresses toxin-induced mitophagy and increases mitochondrial interconnectivity.\",\n      \"method\": \"Stable shRNA PINK1 knockdown; mitochondrial morphology imaging; Drp1 dominant-negative epistasis; ROS measurement; autophagy marker quantification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis with dominant-negative Drp1, stable knockdown with multiple readouts, single lab\",\n      \"pmids\": [\"19279012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Neuronal Pink1 mRNA is cotransported with mitochondria and locally translated in neurites. The outer mitochondrial membrane protein SYNJ2BP and its binding partner SYNJ2 (via an RNA-binding domain) are required to tether Pink1 mRNA to mitochondria, enabling local PINK1 production for mitophagy activation far from the soma.\",\n      \"method\": \"RNA-FISH and live imaging of Pink1 mRNA in neurons; SYNJ2BP/SYNJ2 knockdown; RNA immunoprecipitation; local translation assays; mitophagy readouts in distal neuronal compartments\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct mRNA localization imaging combined with RNA-IP and functional knockdown with mitophagy readout in neurons, single rigorous study with multiple orthogonal methods\",\n      \"pmids\": [\"35216662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Insulin signaling activates AKT/mTOR and inhibits AMPK, which in turn prevents SYNJ2BP phosphorylation within its PDZ domain; this phosphorylation is necessary for SYNJ2BP interaction with the RNA-binding protein SYNJ2 and Pink1 mRNA tethering to mitochondria. Loss of mitochondrial Pink1 mRNA association upon insulin addition is required for proper PINK1 protein activation as a ubiquitin kinase in the mitophagy pathway, placing PINK1 function under metabolic/insulin control. ApoE4-induced insulin resistance retains Pink1 mRNA at mitochondria and impairs PINK1 activity particularly in neurites.\",\n      \"method\": \"AMPK inhibition/activation experiments; phospho-site mutagenesis of SYNJ2BP PDZ domain; RNA immunoprecipitation; PINK1 ubiquitin kinase activity assays; Pink1 mRNA localization imaging in neurons\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — phospho-site mutagenesis, RNA-IP, kinase activity assays and mRNA localization imaging with multiple orthogonal methods in a single study\",\n      \"pmids\": [\"38504131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PINK1 protein localizes to mitochondrial membranes in normal human brain (all cell types, punctate cytoplasmic pattern). Subcellular fractionation of human and rat brain confirms mitochondrial membrane localization. PINK1 is detected in a proportion of Lewy bodies in sporadic Parkinson's disease.\",\n      \"method\": \"Immunohistochemistry and western blotting with anti-PINK1 antibodies; subcellular fractionation of human and rat brain tissue\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct fractionation of primary human and rat brain tissue with validated antibodies, independent replication of localization finding\",\n      \"pmids\": [\"16702191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PINK1 localizes exclusively to mitochondria in cardiomyocytes. Pink1-/- mice develop left ventricular dysfunction and pathological cardiac hypertrophy by 2 months of age with increased mitochondrial ROS, impaired mitochondrial function, fibrosis, and cardiomyocyte apoptosis, demonstrating PINK1 is required for maintaining mitochondrial function and redox homeostasis in the heart.\",\n      \"method\": \"PINK1 immunofluorescence/fractionation in cardiomyocytes; Pink1-/- mouse cardiac phenotyping; mitochondrial function assays; ROS measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with defined cardiac phenotype and mitochondrial functional readouts, single lab\",\n      \"pmids\": [\"21606348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Synphilin-1 interacts with PINK1 and is recruited to mitochondria in a PINK1-dependent manner. Once at mitochondria, synphilin-1 promotes PINK1-dependent mitophagy independently of Parkin by recruiting SIAH-1 E3 ubiquitin ligase to mitochondria, where SIAH-1 promotes mitochondrial protein ubiquitination and mitophagy. PINK1 disease mutants fail to recruit synphilin-1.\",\n      \"method\": \"Co-immunoprecipitation of synphilin-1 and PINK1; siRNA knockdown of synphilin-1 and SIAH-1; LC3/Lamp1 mitochondrial co-localization imaging; Atg5 knockdown epistasis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with multiple knockdown epistasis experiments and imaging readouts, single lab\",\n      \"pmids\": [\"27334109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PINK1/BRPK encodes a serine/threonine-type protein kinase capable of autophosphorylation, as demonstrated with recombinant protein.\",\n      \"method\": \"Recombinant protein expression; in vitro autophosphorylation assay\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro autophosphorylation assay with recombinant protein, single lab, foundational characterization\",\n      \"pmids\": [\"14607334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PINK1 activates AKT phosphorylation at Ser473 through activation of mTORC2, not PI3K. Rictor (mTORC2 component) is phosphorylated upon PINK1 overexpression. This cytoplasmic PINK1 activity promotes cell survival and motility independently of its mitochondrial functions.\",\n      \"method\": \"Overexpression of PINK1 in SH-SY5Y cells; immunoblotting for pAkt-Ser473; rapamycin and PI3K inhibitor controls; Rictor phosphorylation; cell motility assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single overexpression study with indirect readouts, single lab, no direct kinase assay reconstituting PINK1→mTORC2→AKT\",\n      \"pmids\": [\"21177249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FOXO3a transcription factor directly controls Pink1 transcription in mouse and human cells subjected to growth factor deprivation through evolutionarily conserved FOXO binding elements in the Pink1 promoter. PINK1 induction by FOXO3a is required for lymphocyte survival upon growth factor deprivation.\",\n      \"method\": \"FOXO3a overexpression and knockdown; Pink1 promoter-reporter assays; chromatin immunoprecipitation; PINK1 siRNA cell survival assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and promoter reporter assays combined with functional survival readout, single lab\",\n      \"pmids\": [\"19276113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DJ-1 transcriptionally upregulates Pink1 by binding with Foxo3a and directly interacting with the pink1 promoter. DJ-1-null cells show decreased pink1 mRNA and Pink1 protein; the glycolytic and proliferative changes in DJ1-deficient cells are abrogated by Pink1 expression.\",\n      \"method\": \"RT-PCR and western blot of Pink1 in DJ1-null MEFs; chromatin immunoprecipitation of DJ1/Foxo3a at pink1 promoter; Pink1 rescue overexpression; metabolic assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP evidence of direct promoter binding with functional rescue, single lab\",\n      \"pmids\": [\"25670069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PINK1 phosphorylates TUFm (mitochondrial Tu translation elongation factor) at Ser222, creating a phosphoswitch: unphosphorylated TUFm promotes mitophagy via a Parkin-independent route, while p-S222-TUFm is exported to the cytosol where it inhibits mitophagy by impeding Atg5-Atg12 formation. This self-antagonizing PINK1/TUFm mechanism provides robustness to mitophagy regulation.\",\n      \"method\": \"Co-immunoprecipitation of TUFm and PINK1; PINK1 kinase assay with TUFm; phospho-site mutagenesis (S222A/D); subcellular fractionation of p-S222-TUFm; Atg5-Atg12 formation assay; Drosophila genetic validation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase assay, mutagenesis, fractionation and genetic validation in Drosophila, single lab\",\n      \"pmids\": [\"33113344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PINK1 regulates selective ER clearance (ER-phagy) in addition to mitophagy during Drosophila development. PINK1 acts upstream to regulate both Parkin-dependent mitochondrial clearance and Keap1/Cullin3-dependent ER clearance. PINK1 regulates a change in Keap1 localization and Keap1-dependent ubiquitylation of the ER-phagy receptor Rtnl1 to facilitate ER removal. Parkin has the opposite function in ER clearance compared to mitochondrial clearance.\",\n      \"method\": \"Drosophila genetic epistasis (PINK1, parkin, keap1, cullin3, rtnl1 mutants); Keap1 localization imaging; Rtnl1 ubiquitylation assays; autophagy flux assays during development\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with localization and ubiquitylation assays in Drosophila developmental model, single lab\",\n      \"pmids\": [\"37633267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Structural basis for feedforward Parkin activation: phospho-ubiquitin binds to two distinct sites on Parkin—a high-affinity site on RING1 controlling Parkin localization and a low-affinity site on RING0 that releases autoinhibition. The RING0 site has higher affinity for phospho-ubiquitin than for phosphorylated Ubl in trans. Parkin activation by micromolar tetra-phospho-ubiquitin chains, and a Parkin chimera with Ubl replaced by ubiquitin, is activated by PINK1 phosphorylation; mutation of the RING0 binding site abolishes activation.\",\n      \"method\": \"ITC; NMR titrations; ubiquitin vinyl sulfone activity assays; parkin chimera construction and PINK1 phosphorylation assays; mutagenesis of RING0 site\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ITC, NMR, and activity assays with mutagenesis in a single study with multiple orthogonal biochemical methods\",\n      \"pmids\": [\"35491809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"OPTN initiates PINK1/Parkin mitophagy through an unconventional pathway that does not require FIP200 binding or ULK1/2 kinases. Instead, OPTN uses the kinase TBK1, which binds directly to PI3KC3-C1 (class III phosphatidylinositol 3-kinase complex I) to initiate mitophagy. This is mechanistically distinct from NDP52-mediated initiation (which uses FIP200).\",\n      \"method\": \"Gene-edited cell lines lacking autophagy receptors and upstream initiation factors; in vitro reconstitution of TBK1-PI3KC3-C1 interaction; epistasis analysis of FIP200/ULK1/2 dependence\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution combined with gene-edited cell epistasis and multiple orthogonal approaches in a single study\",\n      \"pmids\": [\"37207627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PINK1 associates with TRAF3 via its kinase domain and inhibits Parkin-mediated K48-linked TRAF3 proteasomal degradation, thereby positively regulating RLR-triggered innate immune responses. PINK1 also interacts with YAP1 upon viral infection and impairs YAP1/IRF3 complex formation. PINK1 knockdown reduces cytokine production and IRF3/NF-κB activation upon viral infection.\",\n      \"method\": \"Co-immunoprecipitation of PINK1 with TRAF3 and YAP1; PINK1 knockdown in macrophages; cytokine ELISA; IRF3/NF-κB activation assays; ubiquitylation assays of TRAF3\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP and knockdown study, single lab, limited mechanistic depth\",\n      \"pmids\": [\"31139191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PINK1 phosphorylates ubiquitin predominantly in astrocytes rather than neurons under basal and mitochondrial stress conditions, as determined by pS65-ubiquitin western blotting and immunofluorescence in primary cultures of neurons, astrocytes, microglia, and oligodendrocyte progenitor cells from wild-type and PINK1 knockout rats.\",\n      \"method\": \"pS65-ubiquitin western blotting and immunofluorescence in primary rat brain cell cultures; PINK1 KO comparison; CCCP/valinomycin mitochondrial stress treatment\",\n      \"journal\": \"NPJ Parkinson's disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct comparison across multiple primary cell types with KO controls using two orthogonal readouts, single lab\",\n      \"pmids\": [\"31840043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PINK1 recruits PD-L1 to mitochondria for degradation via the mitophagy pathway. ATAD3A disrupts PINK1-dependent mitophagy-mediated PD-L1 degradation; paclitaxel increases ATAD3A expression to restrain PINK1-dependent mitophagy, causing PD-L1 to accumulate on the tumor cell membrane rather than being degraded at mitochondria.\",\n      \"method\": \"Co-immunoprecipitation; subcellular fractionation of PD-L1; PINK1 knockdown mitophagy assays; ATAD3A overexpression/knockdown; immunotherapy patient cohort correlative imaging\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mechanism partially established by Co-IP and fractionation, but detailed mechanistic reconstitution not described; single lab\",\n      \"pmids\": [\"36627348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PINK1 loss-of-function in substantia nigra dopaminergic neurons (PINK1 knockout mice) causes depolarized mitochondrial membrane potential, mitochondrial fragmentation, and increased basal and H2O2-induced ROS. Wild-type PINK1 overexpression restores mitochondrial membrane potential and morphology; PARK6 disease mutants (G309D, E417G, CΔ145) fail to rescue these defects.\",\n      \"method\": \"Confocal imaging of mitochondrial membrane potential (ΔΨm) and morphology; ROS measurement in PINK1 KO dopaminergic neurons; PINK1 mutant overexpression rescue\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct imaging and functional assays in primary KO neurons with mutant rescue panel, single lab\",\n      \"pmids\": [\"21421046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TRAP1 (TNF receptor-associated protein 1) acts downstream of PINK1 to maintain mitochondrial integrity. TRAP1 overexpression rescues Pink1 loss-of-function phenotypes in Drosophila and mitochondrial fragmentation/dysfunction after siRNA-mediated Pink1 silencing in human SH-SY5Y cells, but does not rescue Parkin deficiency phenotypes, placing TRAP1 specifically downstream of PINK1 (and parallel to/upstream of Parkin).\",\n      \"method\": \"Drosophila genetic epistasis (TRAP1 overexpression in pink1 and park2 mutants); siRNA knockdown of Pink1 in SH-SY5Y with TRAP1 rescue; mitochondrial morphology and function assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in Drosophila validated in human cells with defined pathway placement, single lab\",\n      \"pmids\": [\"23525905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PINK1/Parkin-mediated mitophagy suppresses mtDNA-driven STING inflammatory signaling; in Pink1-/- mice subject to intestinal Gram-negative bacterial infection, mitochondrial antigen presentation and autoimmune mechanisms are engaged, generating cytotoxic mitochondria-specific CD8+ T cells that cause dopaminergic axonal loss and motor impairment reversible by L-DOPA treatment.\",\n      \"method\": \"Pink1-/- mouse intestinal infection model; CD8+ T cell characterization; dopaminergic axonal density measurement; L-DOPA pharmacological rescue; flow cytometry\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo KO mouse model with multiple mechanistic readouts and pharmacological rescue, single lab\",\n      \"pmids\": [\"31316206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"pS65-ubiquitin (PINK1-phosphorylated ubiquitin) is barely detectable under basal conditions but is rapidly induced upon mitochondrial stress in cells; it is amplified by functional Parkin and is dependent on PINK1 kinase activity as confirmed in patient fibroblasts and postmortem brain samples with pathogenic mutations. pS65-Ub is reversible and accumulates as cytoplasmic granules in aged and diseased human brain.\",\n      \"method\": \"Novel anti-pS65-Ub antibodies; western blotting and immunofluorescence in cells, primary neurons, patient fibroblasts, and human postmortem brain; genetic confirmation with PINK1 patient mutations\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — validated antibodies, multiple tissue systems including patient material, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"26162776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The PINK1 p.I368N pathogenic mutation reduces binding to the co-chaperone complex HSP90/CDC37 and abolishes stress-induced interaction with TOM40, preventing PINK1 stabilization on the outer mitochondrial membrane. Structural modeling and functional assays confirm that p.I368N deforms the ATP-binding pocket and abolishes ubiquitin kinase activity.\",\n      \"method\": \"Patient fibroblast biochemical assays; Co-immunoprecipitation of PINK1 with HSP90/CDC37 and TOM40; structural modeling; ubiquitin kinase activity assays; pS65-Ub western blotting\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient fibroblast Co-IP, kinase activity assay, and structural analysis, single lab\",\n      \"pmids\": [\"28438176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"smARF (short mitochondrial ARF) depolarizes mitochondria and promotes PINK1/Parkin-dependent mitophagy in both cell lines and neurons, positioning smARF as an intrinsic signaling molecule upstream of PINK1 and Parkin in the mitophagy pathway.\",\n      \"method\": \"smARF overexpression in cell lines and neurons; Parkin/PINK1 knockdown epistasis; mitochondrial membrane potential measurement; mitophagy flux assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — epistatic knockdown combined with overexpression, mechanism of smARF-to-PINK1 connection not directly established, single lab\",\n      \"pmids\": [\"25217637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Loss of PINK1 and Parkin leads to dysregulation of IP3R activity, robustly increasing ER calcium release. CISD1 (mitoNEET) functions downstream of Parkin to directly control IP3R. Genetic and pharmacological suppression of CISD1 restores increased ER calcium release in PINK1/Parkin null mammalian cells and flies, and rescues PD-related phenotypes (locomotor defects, dopaminergic neurodegeneration) in Drosophila.\",\n      \"method\": \"PINK1/Parkin null mammalian cells and Drosophila; CISD1 genetic and pharmacological suppression; ER calcium release measurements; Drosophila locomotor and dopaminergic neuron assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in mammalian cells and Drosophila with functional calcium and neuronal readouts, single lab\",\n      \"pmids\": [\"37626046\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PINK1 is a mitochondrial outer membrane-localized Ser/Thr kinase that serves as the damage sensor and initiating kinase in the PINK1–Parkin mitophagy pathway: on healthy mitochondria PINK1 is constitutively imported and degraded, but upon mitochondrial depolarization PINK1 accumulates at the TOM–TIM23–VDAC supercomplex (whose cryo-EM structure is now resolved for human PINK1) where it trans-autophosphorylates, undergoes a conformational change to an active state, and phosphorylates Ser65 on ubiquitin and on the Parkin ubiquitin-like domain; phospho-ubiquitin allosterically activates Parkin through a feedforward mechanism involving phospho-Ubl rebinding to the UPD and release of the RING2 catalytic domain; activated Parkin builds K63/K48-ubiquitin chains on outer mitochondrial membrane proteins, recruiting autophagy receptors NDP52 and optineurin (which activate ULK1 and PI3KC3-C1 respectively) to initiate autophagosome formation and mitophagy; beyond mitophagy, PINK1 also regulates ER-phagy via Keap1-dependent ubiquitylation, restrains mtDNA-driven STING innate immune inflammation, controls neuronal Pink1 mRNA localization to mitochondria via SYNJ2BP/SYNJ2 in a metabolic/insulin–AMPK-regulated manner, and modulates IP3R-mediated ER calcium release through the Parkin–CISD1 axis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PINK1 is a mitochondrial Ser/Thr protein kinase that functions as the damage-sensing, initiating kinase of the PINK1–Parkin mitophagy pathway, controlling the selective autophagic clearance of dysfunctional mitochondria [#0, #1]. On healthy, polarized mitochondria PINK1 is held at low levels by voltage-dependent proteolysis, but mitochondrial depolarization triggers rapid accumulation of full-length PINK1 on the outer membrane, an event that is necessary and sufficient to recruit Parkin and that places PINK1 genetically upstream of Parkin [#0]. Upon stress, PINK1 stabilizes at a TOM–TIM23 supercomplex through an interaction between its N-terminal–C-terminal extension module and the cytosolic domain of Tom20, with the dimeric kinase entering through the TOM40 barrel around a central VDAC2 dimer [#6, #7]. PINK1 dimerizes and trans-autophosphorylates, undergoing a conformational change to an active ubiquitin-kinase state in which autophosphorylated PINK1 binds substrates with high affinity through a Ub/UBL-binding groove wider than that of conventional kinases [#5, #8, #9]. Active PINK1 phosphorylates ubiquitin and the Parkin ubiquitin-like domain at Ser65; phospho-ubiquitin allosterically activates Parkin via a feedforward mechanism in which phospho-Ubl and phospho-ubiquitin engage distinct sites that release the autoinhibited RING2/RING0 catalytic core [#1, #4, #29]. The resulting ubiquitin signal on damaged mitochondria recruits the autophagy receptors NDP52 and optineurin independently of Parkin, which in turn engage distinct autophagy-initiation machineries—NDP52 via ULK1/FIP200 and optineurin via TBK1–PI3KC3-C1—to nucleate autophagosomes [#2, #30]. PINK1 stability and activation are governed by an upstream regulatory network including PHB2–PARL–PGAM5, AMBRA1–ATAD3A, TIM23–OMA1, and BNIP3 [#11, #12, #13, #14]. Beyond mitophagy, PINK1 restrains mtDNA-driven STING-dependent type I interferon inflammation, whose loss in mice drives dopaminergic neuron loss and motor deficits [#16], and neuronal Pink1 mRNA is tethered to mitochondria and locally translated via SYNJ2BP/SYNJ2 under insulin–AMPK metabolic control [#18, #19]. Pathogenic PINK1 mutations that disrupt mitochondrial accumulation, kinase activity, or ubiquitin phosphorylation are linked to Parkinson's disease and fail to rescue mitochondrial defects in dopaminergic neurons [#34, #38].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing PINK1's basic enzymatic identity was the necessary starting point: it answered whether the gene product is catalytically active at all.\",\n      \"evidence\": \"recombinant protein in vitro autophosphorylation assay\",\n      \"pmids\": [\"14607334\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No substrate beyond autophosphorylation identified\", \"No subcellular context or pathway placement\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Localizing PINK1 to mitochondrial membranes in human brain anchored the kinase to the organelle whose quality control it would later be shown to govern.\",\n      \"evidence\": \"immunohistochemistry, western blotting and subcellular fractionation of human and rat brain\",\n      \"pmids\": [\"16702191\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Membrane sub-topology not resolved\", \"Functional consequence of mitochondrial localization not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defining voltage-dependent PINK1 accumulation as necessary and sufficient for Parkin recruitment established PINK1 as the upstream damage sensor of mitophagy.\",\n      \"evidence\": \"genetic epistasis with disease mutations, fractionation and live-cell imaging in uncoupler-treated mammalian cells\",\n      \"pmids\": [\"20126261\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular signal linking depolarization to PINK1 stabilization not defined\", \"Direct PINK1 substrate not yet known\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying ubiquitin Ser65 as a direct PINK1 substrate solved the central question of how PINK1 activates Parkin, revealing a phospho-ubiquitin feedforward loop.\",\n      \"evidence\": \"mass spectrometry, in vitro kinase assay with recombinant TcPINK1, cell-free Parkin activation, and phosphomimetic ubiquitin mutants\",\n      \"pmids\": [\"24751536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of phospho-ubiquitin recognition by Parkin not yet resolved\", \"How autophosphorylation gates substrate phosphorylation unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showing PINK1 recruits NDP52 and optineurin independently of Parkin established phospho-ubiquitin as the primary autophagy signal feeding into core autophagy initiation.\",\n      \"evidence\": \"CRISPR knockout of five autophagy receptors in HeLa cells with imaging and flux assays\",\n      \"pmids\": [\"26266977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Distinct initiation machineries used by each receptor not yet defined\", \"In vivo relevance in neurons not tested here\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Structural and biochemical dissection of PINK1 autophosphorylation and Parkin domain rearrangement defined the molecular logic of substrate recognition and feedforward activation.\",\n      \"evidence\": \"TcPINK1 crystal structures with ATP analogue, NMR/SAXS/HDX of PINK1–Parkin Ubl, and 1.8 Å crystal structure of phosphorylated parkin with mutagenesis\",\n      \"pmids\": [\"29991771\", \"29475881\", \"29995846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures used insect/protozoan orthologs rather than human PINK1\", \"Membrane-embedded activation state not captured\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Capturing the PINK1 dimer mid-trans-autophosphorylation explained how an inactive kinase converts to an active ubiquitin kinase and how it orients on the membrane.\",\n      \"evidence\": \"crystal and cryo-EM structures of PhPINK1 in unphosphorylated, dimeric, and phosphorylated active states with phosphorylation assays\",\n      \"pmids\": [\"34933320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Used Pediculus ortholog, not human PINK1\", \"Context of the TOM complex absent from these structures\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mapping two distinct phospho-ubiquitin sites on Parkin clarified how phospho-ubiquitin separately controls Parkin localization and de-repression.\",\n      \"evidence\": \"ITC, NMR titrations, vinyl-sulfone activity assays and parkin chimera/mutagenesis\",\n      \"pmids\": [\"35491809\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetic coordination of the two sites in cells not resolved\", \"Relative contributions of pUb versus pUbl in vivo not quantified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating that PINK1 tethers TOM to TIM23 via its N/C extension–Tom20 interaction defined the supercomplex that holds active PINK1 in place and explained how certain PD mutations block mitophagy.\",\n      \"evidence\": \"Co-IP and native gels of the PINK1–TOM–TIM23 supercomplex with mutagenesis and mitophagy assays in dopamine neurons and midbrain organoids\",\n      \"pmids\": [\"38416681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic detail of the tethering interface not yet resolved here\", \"Stoichiometry within the supercomplex unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A near-atomic cryo-EM structure of dimeric human PINK1 on an endogenous TOM–VDAC array resolved how PINK1 engages the import machinery, providing a human structural framework for the activation model.\",\n      \"evidence\": \"3.1 Å cryo-EM of endogenous human PINK1–TOM–VDAC complex with interface mutagenesis and mitophagy assays across cell systems\",\n      \"pmids\": [\"40080546\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamic transition from import-competent to fully active kinase not captured\", \"Role of VDAC2 dimer in activation not functionally dissected\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linking SYNJ2BP/SYNJ2-mediated Pink1 mRNA tethering to insulin–AMPK signaling placed PINK1 production and activation under metabolic control, particularly in neurites.\",\n      \"evidence\": \"RNA-FISH/live imaging, RNA-IP, SYNJ2BP PDZ phospho-site mutagenesis and PINK1 kinase activity assays in neurons\",\n      \"pmids\": [\"35216662\", \"38504131\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism coupling mRNA release to kinase activation incompletely defined\", \"In vivo contribution to neurodegeneration not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying STING-driven inflammation as the consequence of PINK1/Parkin loss extended PINK1's role beyond organelle turnover to innate immune restraint relevant to neurodegeneration.\",\n      \"evidence\": \"Pink1-/- and Prkn-/- mouse models with mtDNA-mutator and exercise stress, rescued by STING knockout\",\n      \"pmids\": [\"30135585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular trigger of mtDNA release in PINK1-deficient cells not defined\", \"Direct PINK1 substrate in this axis unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse non-canonical PINK1 functions—ER-phagy via Keap1, IP3R/ER calcium via CISD1, TUFm phosphoswitch, and cytoplasmic mTORC2/AKT signaling—are integrated with the core mitophagy program, and whether they share the same activation logic, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Several non-canonical roles rest on single-lab Co-IP/overexpression studies\", \"No unifying mechanism connecting canonical and non-canonical PINK1 activities\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 3, 27]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 8, 23]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005741\", \"supporting_discovery_ids\": [0, 20, 21]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 6, 7, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [0, 2, 30]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 36]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [34, 38]}\n    ],\n    \"complexes\": [\n      \"PINK1–TOM–TIM23 supercomplex\",\n      \"TOM–VDAC array\"\n    ],\n    \"partners\": [\n      \"PARK2\",\n      \"TOMM20\",\n      \"TOMM40\",\n      \"VDAC2\",\n      \"PHB2\",\n      \"AMBRA1\",\n      \"ATAD3A\",\n      \"BNIP3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}